Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Olaptesed pegol by TME Pharma for Glioblastoma Multiforme (GBM): Likelihood of Approval
Olaptesed pegol is under clinical development by TME Pharma and currently in Phase II for Glioblastoma Multiforme (GBM). According to...
Data Insights
Olaptesed pegol by TME Pharma for Glioblastoma Multiforme (GBM): Likelihood of Approval
Olaptesed pegol is under clinical development by TME Pharma and currently in Phase II for Glioblastoma Multiforme (GBM). According to...